F/M Investments »

Dianthus Therapeutics shares owned by F/M Investments

Quarter-by-quarter ownership of Dianthus Therapeutics (DNTH) shares owned by F/M Investments from 13F filings

Historical chart of F/M Investments investment in Dianthus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dianthus Therapeutics held by F/M Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dianthus Therapeutics by F/M Investments

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.5M 36k 97.48

More positions owned by F/M Investments

Ishares Tr Core Us Aggbd Et (AGG)
Dimensional Etf Trust Core Fixed Incom (DFCF)
Invesco Exch Traded Fd Tr Ii Short Term Treas (TBLL)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Apple (AAPL)
Vanguard Intl Equity Index F Allwrld Ex Us (VEU)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Amazon (AMZN)
RBB F/m Us Treasury (TBIL)
RBB Fm Opportunistic (ZHOG)
Palo Alto Networks (PANW)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)

View all positions for F/M Investments

Top funds holding Dianthus Therapeutics

FMR
BlackRock
Wellington Management Company
Fairmount Funds Management
Vanguard Capital Management
Avidity Partners Management
Octagon Capital Advisors
TCG Crossover Management
State Street Corporation
Fred Alger Management
Geode Capital Management
VR Adviser
T. Rowe Price Associates
UBS Group
Deerfield Management Company

View all funds holding Dianthus Therapeutics